HTR1B and migraine disorder: Agonists on 5-HT1B/1D/1F receptors were shown to interfere with neurogenic inflammation11, 13 and the 5-HT1B/1D agonist sumatriptan has been frequently used to interrupt ongoing migraine attacks in the clinic ever since.